<bill session="108" type="h" number="194" updated="2023-01-15T21:04:29Z">
  <state datetime="2003-01-07">REFERRED</state>
  <status>
    <introduced datetime="2003-01-07"/>
  </status>
  <introduced datetime="2003-01-07"/>
  <titles>
    <title type="display">Medicare Market Acquisition Drug Price Act of 2003</title>
    <title type="official" as="introduced">To amend title XVIII of the Social Security Act with respect to reform of payment for drugs and biologicals under the Medicare Program.</title>
    <title type="short" as="introduced">Medicare Market Acquisition Drug Price Act of 2003</title>
  </titles>
  <sponsor bioguide_id="S000810"/>
  <cosponsors>
    <cosponsor bioguide_id="C000380" joined="2003-02-12"/>
  </cosponsors>
  <actions>
    <action datetime="2003-01-07">
      <text>Introduced in House</text>
    </action>
    <action datetime="2003-01-07">
      <text>Sponsor introductory remarks on measure.</text>
      <reference ref="CR E11-12"/>
    </action>
    <action datetime="2003-01-07" state="REFERRED">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2003-01-07">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2003-01-23">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2003-02-03">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
    <committee code="HSWM" name="House Ways and Means" subcommittee="" activity="Referral"/>
    <committee code="HSWM02" name="House Ways and Means" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Auditing"/>
    <term name="Blood"/>
    <term name="Business records"/>
    <term name="Cancer"/>
    <term name="Commerce"/>
    <term name="Drug industry"/>
    <term name="Drugs"/>
    <term name="Economics and Public Finance"/>
    <term name="Finance and Financial Sector"/>
    <term name="Fines (Penalties)"/>
    <term name="Fraud"/>
    <term name="Generic drugs"/>
    <term name="Government Operations and Politics"/>
    <term name="Government paperwork"/>
    <term name="Law"/>
    <term name="Medical fees"/>
    <term name="Medicare"/>
    <term name="Pharmacies"/>
    <term name="Physicians"/>
    <term name="Prescription pricing"/>
    <term name="Social Welfare"/>
  </subjects>
  <amendments/>
  <summary date="2006-11-28T17:35:40Z" status="Introduced in House">Medicare Market Acquisition Drug Price Act of 2003 - Amends title XVIII (Medicare) of the Social Security Act (SSA) to revise payment for drugs and biologicals under Medicare.Directs the Secretary of Health and Human Services, in computing the practice expense component of the Medicare physician fee schedule with respect to payment for services of oncologists, to make adjustments to an oncologist's reported medical supply expenses in order to ensure that they better reflect the actual supply costs of providing such services.Requires the Secretary to provide for a study of the appropriateness of the Medicare payment methodology for blood clotting factors and other biologicals.</summary>
</bill>
